Therapeutic Potential of the Rhizomes of Anemarrhena asphodeloides and Timosaponin A-III in an Animal Model of Lipopolysaccharide-Induced Lung Inflammation
Authors:
Open Access
- 1 November 2018
- journal article
- research article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 26 (6) , 553-559
Abstract
Investigations into the development of new therapeutic agents for lung inflammatory disorders have led to the discovery of plant-based alternatives. The rhizomes of Anemarrhena asphodeloides have a long history of use against lung inflammatory disorders in traditional herbal medicine. However, the therapeutic potential of this plant material in animal models of lung inflammation has yet to be evaluated. In the present study, we prepared the alcoholic extract and derived the saponin-enriched fraction from the rhizomes of A. asphodeloides and isolated timosaponin A-III, a major constituent. Lung inflammation was induced by intranasal administration of lipopolysaccharide (LPS) to mice, representing an animal model of acute lung injury (ALI). The alcoholic extract (50-200 mg/kg) inhibited the development of ALI. Especially, the oral administration of the saponin-enriched fraction (10-50 mg/kg) potently inhibited the lung inflammatory index. It reduced the total number of inflammatory cells in the bronchoalveolar lavage fluid (BALF). Histological changes in alveolar wall thickness and the number of infiltrated cells of the lung tissue also indicated that the saponin-enriched fraction strongly inhibited lung inflammation. Most importantly, the oral administration of timosaponin A-III at 25-50 mg/kg significantly inhibited the inflammatory markers observed in LPS-induced ALI mice. All these findings, for the first time, provide evidence supporting the effectiveness of A. asphodeloides and its major constituent, timosaponin A-III, in alleviating lung inflammation.Keywords
Funding Information
- National Research Foundation of Korea(NRF)
- Ministry of Science, ICT and Future Planning(MSIP) (NRF2016R1A2B4007756)
- Kangwon National University(KNU) (520170392)
- Ministry of Education(Ministry of Education of the Republic of Korea)
This publication has 26 references indexed in Scilit:
- Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary DiseaseClinics in Chest Medicine, 2014
- Effects of Anemarrhena asphodeloides on IgE-mediated passive cutaneous anaphylaxis, compound 48/80-induced systemic anaphylaxis and mast cell activationExperimental and Toxicologic Pathology, 2013
- A challenge to the seven widely believed concepts of COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2013
- TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trialThorax, 2012
- Pelargonium sidoides for acute bronchitis: A systematic review and meta-analysisPhytomedicine, 2008
- Effect of Infliximab on Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease: A Pilot StudyRespiration, 2008
- Identification of Nyasol and Structurally Related Compounds as the Active Principles from Anemarrhena asphodeloides against Respiratory Syncytial Virus (RSV)Chemistry & Biodiversity, 2007
- Herbal medicines for the treatment of COPD: a systematic reviewEuropean Respiratory Journal, 2006
- Protective effects of a standard extract of Mangifera indica L. (VIMANG®) against mouse ear edemas and its inhibition of eicosanoid production in J774 murine macrophagesPhytomedicine, 2006
- Remodeling in Asthma and Chronic Obstructive Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001